Autoimmunity and immunotherapy for cancer

被引：38

作者：

Koon, H ^{[1
]}

Atkins, M ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 07期

关键词：

D O I：

10.1056/NEJMe058307

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：758 / 760

页数：3

共 12 条

[1] Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer [J].

Atkins, M ;

Regan, M ;

McDermott, D ;

Mier, J ;

Stanbridge, E ;

Youmans, A ;

Febbo, P ;

Upton, M ;

Lechpammer, M ;

Signoretti, S .

CLINICAL CANCER RESEARCH, 2005, 11 (10) :3714-3721

[2] HYPOTHYROIDISM AFTER TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS [J].

ATKINS, MB ;

MIER, JW ;

PARKINSON, DR ;

GOULD, JA ;

BERKMAN, EM ;

KAPLAN, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (24) :1557-1563

[3]

ATKINS MB, 1993, THERAPEUTIC APPL INT, P389

[4] Distinct sets of genetic alterations in melanoma [J].

Curtin, JA ;

Fridlyand, J ;

Kageshita, T ;

Patel, HN ;

Busam, KJ ;

Kutzner, H ;

Cho, KH ;

Aiba, S ;

Bröcker, EB ;

LeBoit, PE ;

Pinkel, D ;

Bastian, BC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2135-2147

[5] Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis [J].

Gambineri, E ;

Torgerson, TR ;

Ochs, HD .

CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (04) :430-435

[6] Prognostic significance of autoimmunity during treatment of melanoma with interferon [J].

Gogas, H ;

Ioannovich, J ;

Dafni, U ;

Stavropoulou-Giokas, C ;

Frangia, K ;

Tsoutsos, D ;

Panagiotou, P ;

Polyzos, A ;

Papadopoulos, O ;

Stratigos, A ;

Markopoulos, C ;

Bafaloukos, D ;

Pectasides, D ;

Fountzilas, G ;

Kirkwood, JM .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :709-718

[7] CTLA-4 in autoimmune diseases - a general susceptibility gene tc autoimmunity? [J].

Kristiansen, OP ;

Larsen, ZM ;

Pociot, F .

GENES AND IMMUNITY, 2000, 1 (03) :170-184

[8] Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206 [J].

Ribas, A ;

Camacho, LH ;

Lopez-Berestein, G ;

Pavlov, D ;

Bulanhagui, CA ;

Millham, R ;

Comin-Anduix, B ;

Reuben, JM ;

Seja, E ;

Parker, CA ;

Sharma, A ;

Glaspy, JA ;

Gomez-Navarro, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :8968-8977

[9] Type I interferons (α/β) in immunity and autoimmunity [J].

Theofilopoulos, AN ;

Baccala, R ;

Beutler, B ;

Kono, DH .

ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :307-336

[10] Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target [J].

Thompson, RH ;

Gillettt, MD ;

Cheville, JC ;

Lohse, CM ;

Dong, HD ;

Webster, WS ;

Krejci, KG ;

Lobo, JR ;

Sengupta, S ;

Chen, LP ;

Zincke, H ;

Blute, ML ;

Strome, SE ;

Leibovich, BC ;

Kwon, ED .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17174-17179

← 1 2 →